victoria Frankel
Most scientific innovation isn’t well represented. I fix how it’s communicated.
Over the past decade, I’ve worked across biotech, pharma, diagnostics, and clinical research to support both long-term initiatives and short, high-impact projects that deliver commercial results.
I’ve seen what it takes to build something over years, and I’ve also seen how the right message or campaign can shift momentum quickly and effectively. These experiences have given me significant range to build foundations, shape narratives, and execute with speed when it matters in a way that drives immediate impact.
​
I am passionate about translating complex scientific and clinical work into digestible communication strategies because how we talk about science has significant influence in how it can change the world.

I fundamentally believe that as scientists we have an ethical obligation to ensure that meaningful innovation does not stay buried in technical language or internal scientific dialogues. If it has the potential to improve lives, it needs to be understood, supported, and brought into application. My work has been centered around that belief. I’m ready to bring that experience into a more focused role where I can contribute at a higher level and drive that impact further.
​
Across communications, branding, and marketing efforts, you'll find I have owned end-to-end strategies that have required hands on execution as well as high level strategic consideration. I am an advocate of, "If you have range, you can sustain momentum." As scientific innovation requires equal patience and due diligence, sustaining momentum is everything.
​
Furthermore, I care deeply about helping scientists step into ownership of their narrative and develop the communication skills needed to carry their work further. I have coached and mentored many emerging scientific leaders to help them strengthen how they communicate their work so that their scientific innovation is better understood, brought into real-world impact, and establishes themselves with better credibility on a global scale.
Education
Bachelor's of Science | Dietetics
University of Tennessee
Master's of Science | Cellular and Molecular Biochemistry
University of Tennessee
My academic training combined applied clinical nutrition with a deep understanding of biochemistry and physiology, including research exploring mechanisms of adipogenesis, metabolic regulation, and inflammatory pathways at a cellular level.
This foundation in disease biology and human metabolism ultimately shaped my path into science communication, where I focus on translating complex scientific concepts into meaningful, real-world application across biotech, pharma, and health technology.
Working With the Best Clients and Partners






Examples of where strategic positioning drove better decisions and directly supported growth and market traction.

Pharma
Positioning Clinical Innovation for Investor and Market Adoption
Amytrx Therapeutics is a clinical-stage pharmaceutical company advancing therapies for immune-mediated and inflammatory diseases. Following early clinical progress in a Phase 1/2a trial, the company was preparing for its next stage of development, including a Phase 2b trial and expansion into additional indications.
​
At this stage, the opportunity extended beyond a single indication. While initial development focused on atopic dermatitis, emerging data suggested the underlying mechanism had broader relevance across multiple inflammatory and immune-mediated diseases. The compound also presented potential flexibility in delivery, with applications as an injectable, oral, or topical therapy. This created both an opportunity and a challenge: the company needed to reposition from a single-asset narrative to a platform-level story that could support investor confidence and long-term growth.

strategic Approach
To support this shift, I built investor-facing materials, scientific content, and developed a thought leadership strategy that reinforced credibility while clearly articulating the broader potential of the compound. I also established a structured approach to external visibility, including publication strategy, patient advocacy engagement, and targeted digital presence to increase awareness among key audiences.
​
Takeaway: Establishing a more credible and expansive positioning of the company at a critical stage of development contributed to a successful Series A positioning and strengthened its ability to communicate long-term therapeutic potential.
How success was measured

Explore Supporting Materials
I led the development of a communications and positioning framework that translated clinical data, mechanism of action, and pipeline potential into a cohesive narrative for investors and external stakeholders. This included redefining how the company presented its science, expanding the story beyond a single disease focus, and aligning messaging across scientific, clinical, and commercial priorities.

Diagnostics
Pivoting from COVID-Driven Growth to a Sustainable commercial Strategy
Integrity Laboratories (IL) is a diagnostic testing company for infectious diseases. In early 2020, they became one of the first three diagnostic labs to offer Rapid Testing for COVID-19 for the nation. Pivoting to meet demand at this time, IL ceased all other laboratory processes for other infectious diseases, canceling partnerships with all hospital systems for 14 months. In early 2021, I was brought in as interim Communications Director (1 year) following their rapid COVID-19 expansion. The company had experienced significant regional growth in 2020, but faced the challenge of repivoting as testing demand declined and they returned to offering their full-line of infectious disease diagnostics.
To support market re-entry, I set to identify barriers they were encountering in repositioning the company and reconnecting with established healthcare systems. They faced significant challenges in credibility and trust to meet partner demands as a consequence of their cancelled contracts.
​

strategic Approach
These insights informed a new outreach strategy grounded in real-world sales dynamics and the evolving market needs. Over the next 12 months, I led a cohesive rebranding and repositioning campaign to better align the organization with its long-term growth strategy in infectious disease diagnostics resulting in significant success.

​
​
​
​
​
I established internal communication and alignment systems to improve coordination between the CEO and sales team that generated more consistent messaging and faster decision-making. I also developed educational marketing materials, webinar series, and early campaign assets to support outreach, while equipping the sales team with tools to communicate the value of broader diagnostic offerings. In addition, I implemented and structured their HubSpot CRM to support lead tracking, targeted outreach, and ongoing sales enablement.
Takeaway: Rebuilding trust and repositioning in a constrained market required aligning messaging, operations, and sales around a clear, credible narrative.
How success was measured
Explore Supporting Materials

Clinical
Research
reframing operational capability into credible market growth
Lindus Health is a global contract research organization (CRO) focused on improving how clinical trials are designed, executed, and delivered. Despite strong operational capabilities and a differentiated model, the company faced a core challenge: its messaging was not effectively communicating its value, which was limiting growth and contributing to missed revenue targets.
​
I was brought in to assess and redefine how the company positioned itself in a competitive CRO landscape. This began with deep immersion in the clinical trials ecosystem, including direct interviews with scientists, clinical teams, and stakeholders across trial design and execution. I evaluated the experience from multiple angles, including sponsors seeking CRO partners, patients navigating trial participation, and internal teams responsible for delivery. This surfaced clear gaps between how Lindus operated and how it was perceived in market.
​
​

The organization had strong clinical and operational expertise, but lacked a structured approach to marketing, brand strategy, and external communication. There was no clear articulation of differentiation, and credibility was not being established in a way that resonated with sponsors. I led a full assessment of brand and messaging, identifying where positioning fell short and where opportunities existed to better align the company’s capabilities with real-world sponsor expectations.
strategic Approach
Proud mentor
for over
20 startups


When asked what my proudest moments of my career have been, I reflect most on the many mentorship opportunities I have had the privilege to participate in.
​
As a Business Communications mentor to my local Entrepreurship Center, as a Business Mentorship Coach at Let Her Lead, and as a Presentation Coach for Physician MBAs/Executive MBA students at the University of Tennessee, I have donated hundreds of hours to advising new leaders on building their brand and advancing their product or service to market. I’ve come to believe that real impact is created by the people willing to build. These are leaders who take on the uncertainty of an entrepreneurial path and carry innovation far enough to become something that can truly improve lives.




.png)

